Abstract
A 49-year-old woman presented as an acute admission with persistent vomiting and an inability to tolerate both solids and liquids. Five weeks prior to the admission she had an Elipse swallowable intragastric balloon placed into her stomach as an aid to weight loss. This type of balloon stays inflated inside the stomach for 16 weeks before disintegrating and passing through the gastrointestinal tract. Observations and blood parameters were unremarkable but abdominal radiograph indicated that the balloon had undergone spontaneous hyperinflation—a rare complication. At gastroscopy, the balloon was found to fill the entire stomach volume causing dysphagia. The balloon was punctured endoscopically, contents suctioned and remnants retrieved through the gastroscope. The patient commenced oral intake the following day and was discharged home with no further symptoms at 12-week follow-up.
Reference12 articles.
1. Safety and Effectiveness of the Intragastric Balloon for Obesity. A Meta-Analysis
2. The safety and efficacy of the procedureless intragastric balloon;Alsabah;Surg Obes Relat Dis,2018
3. Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study;Machytka;Endoscopy,2017
4. The Procedureless Elipse gastric balloon program: multicenter experience in 1770 consecutive patients;Ienca;Obes Surg,2020
5. de Souza TF , Grecco E , Usuy EN . Hyperinflated intragastric balloon. In: Galvao Neto M , Silva LB , EN UJ , et al , eds. Intragastric balloon for weight management: a practical guide. Cham: Springer International Publishing, 2020: 171–8.